GlaxoSmithKline

Five Prime and GSK form second strategic alliance

Wednesday, April 18, 2012 02:28 PM

Five Prime Therapeutics, a biotech based in San Francisco, has entered into its second strategic drug discovery alliance with GlaxoSmithKline in two years.

More... »

Mymetics ropes in Dendreon vets

Wednesday, April 11, 2012 12:58 PM

Mymetics, a Swiss-based biotech of mucosal and virosomal-based vaccines for infectious diseases, has appointed Grant E. Pickering as president and CEO and Christopher S. Henney as chairman of the board of directors. The changes were made in connection with Mymetics’ efforts to obtain additional financing and to advance the development of its vaccine platform.

More... »

Syndax initiates phase I/II study in metastatic breast cancer

Monday, April 9, 2012 04:42 PM

Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company based in Waltham, Mass., has initiated a phase I/II study combining its lead product entinostat with lapatinib ditosylate (Tykerb) in patients with locally recurrent or distant relapsed metastatic breast cancer previously treated with trastuzumab (Herceptin).

More... »

GSK invests $794 million in U.K., creates jobs

Friday, March 23, 2012 12:44 PM

GlaxoSmithKline will invest more than $794 million in the U.K. across its manufacturing sites and a new facility in Cumbria to increase production of key active ingredients for its pharmaceutical products and vaccines, creating 1,000 new jobs.

More... »

GSK selects Infosys and Fabric Worldwide to optimize digital strategy

Wednesday, March 21, 2012 10:11 AM

Infosys, a provider of business consulting and technology, engineering and outsourcing services, has formed a partnership with GlaxoSmithKline (GSK), along with Fabric Worldwide, to optimize digital channels across its global consumer healthcare and pharmaceuticals business lines.

More... »

Index Ventures launches $198 million life sciences fund

Wednesday, March 21, 2012 09:26 AM

Index Ventures, a venture capital firm, has launched its first fund solely dedicated to making investments in the life sciences sector.

More... »

GSK launches U.K. apprenticeship program

Wednesday, March 14, 2012 10:37 AM

GlaxoSmithKline (GSK) has launched a new multidisciplinary apprenticeship program aimed at 16- to 24-year-olds, offering positions at the company’s U.K. manufacturing, R&D and corporate sites.

More... »

Dendreon appoints three to executive team

Wednesday, March 14, 2012 09:10 AM

Seattle, Wash.-based Dendreon has appointed three new members to its executive team:

More... »

GlaxoSmithKline and Angiochem collaborate on treatments for LSDs

Thursday, March 1, 2012 05:55 AM

Angiochem, a clinical-stage biotechnology company, has partnered with GlaxoSmithKline (GSK) to discover, develop and commercialize treatments for lysosomal storage diseases (LSDs).

More... »

Dr. Stephen Chen named chairman, CEO of Amarillo

Monday, February 27, 2012 10:10 AM

Amarillo Biosciences, a U.S. biotechnology firm, has appointed Dr. Stephen T. Chen CEO and chairman of the board.

More... »